Related Experiment Video
Updated: Aug 19, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors
1Genética y Biología Molecular, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, 1113 Buenos Aires, Argentina.
Abstract:
Mutations in proto-oncogenes and tumor suppressor genes have been associated with tumor development and/or progression in many neoplasms. It has been reported that parathyroid tumors have deletions affecting the retinoblastoma gene (RB), and overexpression of cyclin D1 (Cyc D1). The aim of the present study was to evaluate the alterations in the components of the pRB pathway in parathyroid adenomas and parathyroid aggressive tumors, including patterns of expression of pRB, Cyc D1, and p16/INK4A. Paired normal and tumor DNA from 6 parathyroid adenomas and 5 aggressive tumors were analyzed for loss of heterozygosity (LOH) at the RB locus. The expression of pRB, Cyc D1 and p16 was studied in 4 adenomas and 5 aggressive tumors. RB LOH was found in 1 of 6 adenomas, and in 1 of 2 informative aggressive tumors. Immunohistochemical analysis revealed undetectable pRB in 4 of 5 aggressive tumors and presence of pRB in all adenomas. Conversely, Cyc D1 expression was found in 3 of 4 aggressive tumors, but was undetectable in the adenomas. Expression of p16 was identified only in one aggressive tumor. Thus, alterations in the pRB pathway seem to prevail in the aggressive form of parathyroid neoplasms. Our results warrant further investigation of these cell cycle regulators in order to determine their potential role as tumor markers in parathyroid tumors.
Insights
Alterations in the pRB pathway, including the retinoblastoma gene (RB) and cyclin D1 (Cyc D1), are more common in aggressive parathyroid tumors than adenomas. These findings suggest potential tumor markers for parathyroid neoplasms.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Proto-oncogene and tumor suppressor gene mutations are linked to cancer development.
- Parathyroid tumors may exhibit retinoblastoma gene (RB) deletions and cyclin D1 (Cyc D1) overexpression.
Purpose of the Study:
- To investigate alterations in the pRB pathway components in parathyroid adenomas and aggressive tumors.
- To analyze the expression patterns of pRB, Cyc D1, and p16/INK4A in these tumors.
Main Methods:
- Analysis of paired normal and tumor DNA from 6 parathyroid adenomas and 5 aggressive tumors for loss of heterozygosity (LOH) at the RB locus.
- Immunohistochemical analysis of pRB, Cyc D1, and p16 expression in tumor samples.
Main Results:
- RB LOH was detected in one adenoma and one aggressive tumor.
- Undetectable pRB was observed in 4 out of 5 aggressive tumors, while present in all adenomas.
- Cyc D1 was overexpressed in 3 out of 4 aggressive tumors but undetectable in adenomas. p16 expression was found in only one aggressive tumor.
Conclusions:
- Alterations in the pRB pathway are more prevalent in aggressive parathyroid neoplasms.
- Further research into these cell cycle regulators may identify potential tumor markers for parathyroid tumors.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...

